Tvangslidelse, OCD
Sist revidert:
Sist revidert av:Anders Lillevik Thorsen
Definisjon:
Tvangslidelse eller obsessiv-kompulsiv lidelse (OCD) kjennetegnes ved tilbakevende og påtrengende tvangstanker og/eller gjentatte tvangshandlinger som er tidkrevende eller forårsaker betydelig ubehag eller svekket fungeringsevne
Forekomst:
Livstidsprevalensen angis til 1-3%
Symptomer:
Tvangstanker eller obsesjoner er påtrengende og ubehagelige tanker, impulser eller bilder. Selv om pasienten opplever dette som irrasjonelt utløser det ubehag og trang til å utføre tvangshandlinger. Tvangshandlinger eller kompulsjoner er gjentatte fysiske eller mentale handlinger som utføres for å dempe ubehaget eller forhindre de fryktede hendelsene
Funn:
Klinisk undersøkelse er normal bortsett fra symptomene på tvangslidelse
Diagnostikk:
Tilleggsundersøkelser er vanligvis ikke påkrevd
Behandling:
Ubehandlet vil tilstanden typisk vedvare, men det finnes effektive psykologisk og farmakologiske behandlinger. Kognitiv atferdsterapi (KAT) med eksponering og responsprevensjon (ERP) er førstevalg. Oppstart av behandling er ofte sterkt forsinket
- Stein DJ, Costa DLC, Lochner C, et al. Obsessive-compulsive disorder. Nat Rev Dis Primers. 2019 Aug 1;5(1):52. PMID: 31371720. PubMed
- Ruscio AM, Stein DJ, Chiu WT, Kessler RC. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry. 2010 Jan;15(1):53-63. Epub 2008 Aug 26. PMID: 18725912. PubMed
- Thorsen AL, Hagland P, Radua J, et al. Emotional Processing in Obsessive-Compulsive Disorder: A Systematic Review and Meta-analysis of 25 Functional Neuroimaging Studies. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Jun;3(6):563-571. Epub 2018 Feb 3. PMID: 29550459. PubMed
- Boedhoe PSW, van Rooij D, Hoogman M, et al. Subcortical Brain Volume, Regional Cortical Thickness, and Cortical Surface Area Across Disorders: Findings From the ENIGMA ADHD, ASD, and OCD Working Groups. Am J Psychiatry. 2020 Sep 1;177(9):834-843. Epub 2020 Jun 16. Erratum in: Am J Psychiatry. 2020 Sep 1;177(9):843. PMID: 32539527. PubMed
- Picó-Pérez M, Moreira PS, de Melo Ferreira V, et al. Modality-specific overlaps in brain structure and function in obsessive-compulsive disorder: Multimodal meta-analysis of case-control MRI studies. Neurosci Biobehav Rev. 2020 May;112:83-94. Epub 2020 Jan 30. PMID: 32006553. PubMed
- Thorsen AL, van den Heuvel OA, Hansen B, Kvale G. Neuroimaging of psychotherapy for obsessive-compulsive disorder: A systematic review. Psychiatry Res. 2015 Sep 30;233(3):306-13. Epub 2015 May 16. PMID: 26228566. PubMed
- Mataix-Cols D, Boman M, Monzani B, Rück C, et al. Population-based, multigenerational family clustering study of obsessive-compulsive disorder. JAMA Psychiatry. 2013 Jul;70(7):709-17. PMID: 23699935. PubMed
- Eilertsen T, Hansen B, Kvale G, Abramowitz JS, Holm SEH, Solem S. The Dimensional Obsessive-Compulsive Scale: Development and Validation of a Short Form (DOCS-SF). Front Psychol. 2017 Sep 5;8:1503. PMID: 28928693. PubMed
- Öst LG, Riise EN, Wergeland GJ, Hansen B, Kvale G. Cognitive behavioral and pharmacological treatments of OCD in children: A systematic review and meta-analysis. J Anxiety Disord. 2016 Oct;43:58-69. Epub 2016 Aug 13. PMID: 27632568. PubMed
- Öst LG, Havnen A, Hansen B, Kvale G. Cognitive behavioral treatments of obsessive-compulsive disorder. A systematic review and meta-analysis of studies published 1993-2014. Clin Psychol Rev. 2015 Aug;40:156-69. Epub 2015 Jun 14. PMID: 26117062. PubMed
- Zhou DD, Zhou XX, Lv Z, et al. Comparative efficacy and tolerability of antipsychotics as augmentations in adults with treatment-resistant obsessive-compulsive disorder: A network meta-analysis. J Psychiatr Res. 2019 Apr;111:51-58. Epub 2019 Jan 14. PMID: 30677645. PubMed
- Thorsen AL, Kvale G, Hansen B, van den Heuvel OA. Symptom dimensions in obsessive-compulsive disorder as predictors of neurobiology and treatment response. Curr Treat Options Psychiatry. 2018 Mar;5(1):182-194. Epub 2018 Feb 23. PMID: 30237966. PubMed
- Knopp J, Knowles S, Bee P, Lovell K, Bower P. A systematic review of predictors and moderators of response to psychological therapies in OCD: do we have enough empirical evidence to target treatment? Clin Psychol Rev. 2013 Dec;33(8):1067-81. Epub 2013 Sep 5. PMID: 24077387. PubMed
- Pearcy CP, Anderson RA, Egan SJ, Rees CS. A systematic review and meta-analysis of self-help therapeutic interventions for obsessive-compulsive disorder: Is therapeutic contact key to overall improvement? J Behav Ther Exp Psychiatry. 2016 Jun;51:74-83. Epub 2015 Dec 30. PMID: 26794856. PubMed
- Vogel PA, Solem S, Hagen K, Moen EM, Launes G, Håland ÅT, Hansen B, Himle JA. A pilot randomized controlled trial of videoconference-assisted treatment for obsessive-compulsive disorder. Behav Res Ther. 2014 Dec;63:162-8. Epub 2014 Oct 30. PMID: 25461792. PubMed
- Launes G, Hagen K, Sunde T, Öst LG, Klovning I, Laukvik IL, Himle JA, Solem S, Hystad SW, Hansen B, Kvale G. A Randomized Controlled Trial of Concentrated ERP, Self-Help and Waiting List for Obsessive- Compulsive Disorder: The Bergen 4-Day Treatment. Front Psychol. 2019 Nov 15;10:2500. PMID: 31803089. PubMed
- Wootton BM. Remote cognitive-behavior therapy for obsessive-compulsive symptoms: A meta-analysis. Clin Psychol Rev. 2016 Feb;43:103-13. Epub 2015 Oct 20. PMID: 26494179. PubMed
- Simpson HB. Pharmacotherapy for obsessive-compulsive disorder in adults. UpToDate. 2015. www.uptodate.com
- Simpson HB, Huppert JD, Petkova E, et al. Response versus remission in obsessive-compulsive disorder. J Clin Psychiatry. 2006 Feb;67(2):269-76. PMID: 16566623. PubMed
- Issari Y, Jakubovski E, Bartley CA, et al. Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis. J Clin Psychiatry. 2016 May;77(5):e605-11. PMID: 27249090. PubMed
- Dold M, Aigner M, Lanzenberger R, Kasper S. Antipsychotic Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: An Update Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials. Int J Neuropsychopharmacol. 2015 May 4;18(9):pyv047. PMID: 25939614. PubMed
- Piacentini J, Woods DW, Scahill L, et al. Behavior therapy for children with Tourette disorder: a randomized controlled trial. JAMA. 2010 May 19;303(19):1929-37. PMID: 20483969. PubMed
- Skarphedinsson G, Compton S, Thomsen PH, et al. Tics Moderate Sertraline, but Not Cognitive-Behavior Therapy Response in Pediatric Obsessive-Compulsive Disorder Patients Who Do Not Respond to Cognitive-Behavior Therapy. J Child Adolesc Psychopharmacol. 2015 Jun;25(5):432-9. PMID: 26091197. PubMed
- Zhou DD, Wang W, Wang GM, Li DQ, Kuang L. An updated meta-analysis: Short-term therapeutic effects of repeated transcranial magnetic stimulation in treating obsessive-compulsive disorder. J Affect Disord. 2017 Jun;215:187-196. doi: 10.1016/j.jad.2017.03.033. Epub 2017 Mar 18. PMID: 28340445. PubMed
- Visser HA, van Oppen P, van Megen HJ, et al. Obsessive-compulsive disorder; chronic versus non-chronic symptoms. J Affect Disord. 2014 Jan;152-154:169-74. Epub 2013 Sep 13. PMID: 24084621. PubMed
- Wheaton MG, Galfalvy H, Steinman SA, et al. Patient adherence and treatment outcome with exposure and response prevention for OCD: Which components of adherence matter and who becomes well? Behav Res Ther. 2016 Oct;85:6-12. Epub 2016 Jul 29. PMID: 27497840. PubMed
- Visser H, Megen H, Oppen P, et.al. The impact of poor insight on the course of Obsessive-Compulsive Disorder in patients receiving naturalistic treatment. J Obsessive Compuls Relat Disord 2017; 13: 42-8. doi:10.1016/j.jocrd.2017.03.003 DOI
- Hansen B, Kvale G, Hagen K, Havnen A, Öst LG. The Bergen 4-day treatment for OCD: four years follow-up of concentrated ERP in a clinical mental health setting. Cogn Behav Ther. 2019 Mar;48(2):89-105. Epub 2018 Aug 8. PMID: 30088441. PubMed
- Batelaan NM, Bosman RC, Muntingh A, et al. Risk of relapse after antidepressant discontinuation in anxiety disorders, obsessive-compulsive disorder, and post-traumatic stress disorder: systematic review and meta-analysis of relapse prevention trials. BMJ. 2017 Sep 13;358:j3927. Erratum in: BMJ. 2017 Sep 25;358:j4461. PMID: 28903922. PubMed
- Anders Lillevik Thorsen, psykolog og PhD, Haukeland universitetssykehus og Universitet i Bergen, Bergen
- Marte Jürgensen, overlege og PhD, Haukeland universitetssykehus, Bergen
- Bjarne Hansen, professor, psykologspesialist og PhD, Haukeland universitetssykehus og Universitet i Bergen, Bergen
Tidligere fagmedarbeidere
- Olav Thorsen, spesialist allmennmedisin, Klubbgaten legesenter, Stavanger
- K Gunnar Götestam, professor, Psykiatrisk institutt, Norges teknisk-naturvitenskapelige universitet, Trondheim